Follow

Gradientech AB

Nasdaq First North GM (Sweden)

Gradientech develops and provides microscale tools for live imaging of cell behavior in response to defined concentration gradients.
Our patented microfluidic platform offers controllable gradients that enables you to analyse live cell responses at high resolution and with full control of the chemotactic environment.

Sector:
HEALTH CARE
>
Biotechnology
 
News
No available news yet for Gradientech AB
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
Nasdaq First North GM
Sweden (SE)
Details of share in Gradientech AB with ticker
Status
Inactive
Order book id
Amount of instruments
Par value
Currency
SEK
Type
Price
Pre-money
Time
Files
Listing
2021
Direct listing of Gradientech AB on Nasdaq First North GM
People
Sara Thorslund
CEO
Gisela Sitbon
Chairman of the board
Rolf Ehrnström
Board member
Henrik Didner
Board member
Ted Elvhage
Board member
Karl Xavier
Board member
Simon Turner
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Dag Hammarskjoelds Vaeg 34
Zip code
751 83
City/district
Uppsala
Country
Sweden (SE)
Registration number
556788-9505
LEI code
254900HPV6QRK8OIDQ02
First trade date
Registration date
14 Sep 2009
Short name
Gradientech

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More